Related Experiment Video
Updated: May 15, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management
Sudarshan Balla1, Maen B Nusair, Martin A Alpert
1Division of Cardiovascular Medicine, University of Missouri School of Medicine, Columbia, MO, USA.
Insights
Heart disease is the leading cause of death for chronic kidney disease (CKD) patients, with atherosclerosis accelerating due to traditional and non-traditional risk factors. Standard cardiovascular therapies are often ineffective in this population.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Heart disease is the primary cause of mortality in chronic kidney disease (CKD) patients, especially those on dialysis.
- Atherosclerotic cardiovascular disease (CVD) contributes significantly to these deaths, driven by accelerated atherosclerosis in CKD.
- CKD patients exhibit a high prevalence of traditional CVD risk factors, which are often exacerbated by the disease itself.
Purpose of the Study:
- To investigate the complex relationship between chronic kidney disease (CKD) and cardiovascular disease (CVD).
- To understand why standard CVD risk factor modification therapies are less effective in CKD patients.
- To highlight CKD as a potential independent risk factor for coronary heart disease (CHD).
Main Methods:
- Review of existing literature on cardiovascular risk in CKD patients.
- Analysis of the impact of traditional and non-traditional CVD risk factors in the CKD population.
- Evaluation of the efficacy of current CVD risk reduction strategies in CKD.
Main Results:
- Atherosclerosis is accelerated in CKD due to aggravated traditional risk factors (hypertension, dyslipidemia) and unique non-traditional factors.
- CKD itself may be an independent risk factor for CVD, particularly coronary heart disease (CHD).
- Therapies effective in the general population show limited success in mitigating CV risk in CKD patients.
Conclusions:
- CKD significantly increases cardiovascular risk through multiple mechanisms, including accelerated atherosclerosis.
- Novel therapeutic approaches are needed to effectively manage cardiovascular risk in patients with chronic kidney disease.
- Further research is essential to develop tailored interventions for this vulnerable patient group.
Abstract:
Heart disease is the most common cause of death in patients with chronic kidney disease (CKD), particularly in those receiving dialysis. Atherosclerosic cardiovascular (CV) disease (CVD) accounts for a large number of these deaths. Atherosclerosis is accelerated in patients with CKD due predominantly to the high prevalence of traditional CVD risk factors in the CKD population. CKD aggravates pre-existent traditional risk factors such as hypertension and dyslipidemia due to secondary renal parenchymal hypertension and secondary dyslipidemia. In addition, a variety of non-traditional risk factors that occur commonly in CKD patients contribute to CV risk. Recent studies suggest that CKD itself may be an independent risk factor for CVD, particularly coronary heart disease (CHD). Many therapies aimed at CV risk factor modification that have been successful in reducing CV risk in the general population are less effective or ineffective in favorably modifying CV risk in CKD.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Atherosclerosis IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
